Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07059299Phase 1Recruiting
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
Esophageal AdenocarcinomaEsophagogastric Junction AdenocarcinomaGastric Adenocarcinoma+2 more
PrincipalinvestigatorStart date: 2025-12-12

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Salah Eddin Al-Batran, Prof. Dr.

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Similar
2 trials

Shared therapeutic areas:

Esophageal AdenocarcinomaEsophagogastric Junction AdenocarcinomaGastric Adenocarcinoma+2 more

Worked with same sponsors:

BeiGeneInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest+1 more
Collaborated on 1 trial
Similarity Score54%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Esophageal AdenocarcinomaGastric Adenocarcinoma
Similarity Score12%

Manish Shah, MD

Weill Medical College of Cornell University

Related
7 trials

Shared therapeutic areas:

Gastric AdenocarcinomaEsophageal Adenocarcinoma
Similarity Score12%

Hyun Kim, M.D.

Washington University School of Medicine

Related
5 trials

Shared therapeutic areas:

Gastric Adenocarcinoma
Similarity Score6%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Neoadjuvant Therapy
Similarity Score6%

jiafu ji, MD

Peking University Cancer Hospital & Institute

Related
7 trials

Shared therapeutic areas:

Gastric Adenocarcinoma
Similarity Score6%

Kezhong Chen, MD

Peking University People's Hospital

Related
4 trials

Shared therapeutic areas:

Neoadjuvant Therapy
Similarity Score6%

Julian Abrams, MD

Columbia University

Related
5 trials

Shared therapeutic areas:

Esophageal Adenocarcinoma
Similarity Score6%

Zhen Zhang, MD

Fudan University

Related
9 trials

Shared therapeutic areas:

Neoadjuvant Therapy
Similarity Score6%

Yanhong Deng, M.D.

Sixth Affiliated Hospital, Sun Yat-sen University

Related
8 trials

Shared therapeutic areas:

Neoadjuvant Therapy
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07059299Phase 1PrincipalInvestigator

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Esophageal AdenocarcinomaEsophagogastric Junction AdenocarcinomaGastric Adenocarcinoma+2 more
Recruiting

All 1 trials loaded